Rather than showing increased drinking, treated rats exhibited a trend toward reduced alcohol intake compared to baseline (P=0.073)
Medical disclaimer: The information provided in this article is intended for general knowledge and should not be taken as medical advice
HCV genotype 6a escape from and resistance to velpatasvir, pibrentasvir, and sofosbuvir in robust infectious cell culture models
Real-world impact of adding a glucagon-like peptide-1 receptor agonist compared with basal insulin on metabolic targets in adults living with type 2 diabetes and chronic kidney disease already treated with a sodium-glucose co-transporter-2 inhibitor: the impact GLP-1 CKD study
L-carnitine therapy in non-alcoholic steatohepatitis
Four of the articles reviewed showed that there was increased incidence of aspiration among GLP-1 RA users (Australian Diabetes Society, National Association of Clinical Obesity Services, Gastroenterological Society of Australia, and Australian and New Zealand College of Anaesthetists n.d.)